Search

everythinglearnresearchcommunity

for

Search:↓

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Finasteride effectively treats hair loss in transgender men with few side effects.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

AR gene not major factor in female hair loss; different from male hair loss.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Alternative treatments show promise for hair growth beyond traditional methods.

Non-obese women with hair loss have higher heart disease risk.

EF and PXE not closely related.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Mutation in hairless gene may increase hair loss risk.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Resistance training might help with PCOS symptoms, but more research is needed.